How ARA-290 Works

ARA-290 is a synthetic peptide modeled from the structural helix of erythropoietin (EPO), a natural hormone known for protecting cells and stimulating blood production. However, ARA-290 is specifically modified to interact only with the body’s protective repair pathways, bypassing traditional blood-building mechanisms completely:

• Selective Innate Repair Receptor (IRR) Activation: It selectively binds to the Innate Repair Receptor (IRR), a special cell receptor that switches on only during severe tissue injury, stress, or inflammation.

• Blocks Chronic Neuropathic Inflammation: When the IRR is activated by ARA-290, it shuts down the production of damaging pro-inflammatory cytokines like TNF-alpha and Interleukin-6. In testing models, this directly calms the hyper-excited nerve pathways responsible for chronic neuropathic pain.

• Small Fiber Neuropathy Repair: It is heavily researched for its potential to protect and repair damaged small nerve fibers. By stabilizing these micro-nerve pathways, it helps restore normal sensory signaling in neuropathic models.

• Zero Impact on Red Blood Cells: Traditional EPO stimulates red blood cell production, which can dangerously thicken the blood. ARA-290 does not bind to the classical EPO receptor, meaning it carries zero risk of altering red blood cell counts, making it a highly isolated research tool for cellular protection.

Chemical Properties